Pharmacotherapy: Latest Developments

Pharmacotherapy: Latest Developments

This session will cover the latest advancements in pharmacotherapy for cardiovascular diseases. We will explore novel drug classes, including PCSK9 inhibitors, SGLT2 inhibitors, and RNA-based therapies, highlighting their mechanisms, benefits, and clinical applications. Discussions will focus on the evolving landscape of heart failure treatments, lipid-lowering therapies, and hypertension management. Additionally, we will examine the role of personalized medicine in optimizing treatment regimens and minimizing side effects. The session will provide insights into ongoing clinical trials, emerging drug candidates, and how these developments are shaping the future of cardiovascular pharmacotherapy for better patient outcomes.

Related Sessions



Quick Links

Contact Us

Scitechseries Publishing Limited
71-75, Shelton, Covent Garden
London, WC2H 9JQ

Email: heart@scitechconference.com
Phone: +44 2045874848
WhatsApp: +44 2045250803

© 2022 All Rights Reserved by Scitechseries
Terms and Conditions | Privacy Policy